Showing results (1201-1210 of 9,035) with videos related to
Sort By:
Pageof 904
BMC Psychiatry|October 27, 2021
Risk factors for mental health symptoms during the COVID-19 pandemic in ophthalmic personnel and students in USA (& Canada): a cross-sectional survey studyYi Pang, Meng Li, Connor Robbs, et al.BMC Psychiatry|October 27, 2021
Exploring low grade inflammation by soluble urokinase plasminogen activator receptor levels in schizophrenia: a sex-dependent association with depressive symptomsTherese Torgersen Bigseth, John Abel Engh, Jens Egeland, et al.BMC Psychiatry|February 22, 2022
A pragmatic randomized controlled trial of a group self-management support program versus treatment-as-usual for anxiety disorders: study protocolPasquale Roberge, Janie Houle, Jean-Rémy Provost, et al.BMC Psychiatry|February 20, 2022
Cardiometabolic outcomes among schizophrenia patients using antipsychotics: the impact of high weight gain risk vs low weight gain risk treatmentRezaul Khandker, Farid Chekani, Brendan Limone, et al.BMC Psychiatry|February 16, 2022
The role of migration in mental healthcare: treatment satisfaction and utilizationGabriele Gaigl, Esther Täumer, Andreas Allgöwer, et al.BMC Psychiatry|February 16, 2022
Social support and depressive symptoms: exploring stigma and self-efficacy in a moderated mediation modelDong-Fang Wang, Ya-Nan Zhou, Yue-Heng Liu, et al.BMC Psychiatry|February 23, 2022
Neurocognitive effects of repeated ketamine infusion treatments in patients with treatment resistant depression: a retrospective chart reviewDanika Dai, Courtney Miller, Violeta Valdivia, et al.BMC Psychiatry|May 1, 2019
A retrospective analysis of determinants of involuntary psychiatric in-patient treatmentMario Schmitz-Buhl, Stefanie Kristiane Gairing, Christian Rietz, et al.BMC Psychiatry|May 5, 2019
An evaluation of large group cognitive behaviour therapy with mindfulness (CBTm) classesVishal K Thakur, Jacquelyne Y Wong, Jason R Randall, et al.BMC Psychiatry|April 18, 2019
Real-life assessment of aripiprazole monthly (Abilify Maintena) in schizophrenia: a Canadian naturalistic non-interventional prospective cohort studySally Mustafa, Joanna Bougie, Maia Miguelez, et al.Pageof 904